Previous Article | Next Article ![]()
Infection and Immunity, July 1999, p. 3334-3338, Vol. 67, No. 7
Division of Infection & Immunity,
Received 28 August 1998/Returned for modification 28 January
1999/Accepted 5 April 1999
We have investigated the possibility that nitric oxide (NO)
synthesis may affect the course of a trypanosome infection via T-cell
responses using mice deficient in inducible NO synthase (iNOS).
Parasitemia levels increased at the same rate in both iNOS-deficient homozygous and control heterozygous mice, and peak parasitemia values were the same in both groups. However, the heterozygous mice maintained higher parasitemia levels after the peak
of an infection than the homozygous mice due to a decrease in the rate
of clearance of parasites. In iNOS-deficient mice there
was an increase in the numbers of total CD4+ cells and
activated (interleukin-2 receptor-expressing)
CD4+ cells in infected mice compared with the numbers in
uninfected mice. Spleen cells from infected iNOS-deficient mice
displayed increased proliferative responses and gamma interferon
secretion when stimulated in vitro than those of control mice. These
data suggest that NO production depresses T-helper 1-like responses generated during Trypanosoma brucei infections, thus
promoting the survival of the parasite.
Trypanosoma brucei
infections cause African sleeping sickness in humans and nagana in
cattle. Infections are accompanied by severe immunodepression in
humans, domestic animals, and experimental rodent hosts, one facet of
which is a profound depression of lymphocyte responsiveness (2,
25). Immunodepression is mediated by activated "suppressor"
macrophages (2, 5, 8, 13, 18, 20, 25). Lymphocyte
unresponsiveness is associated with depressed interleukin-2 (IL-2) and
IL-2 receptor expression (18, 20, 22) and is gamma
interferon (IFN- The NO synthesized by splenic and peritoneal macrophages from
trypanosome-infected mice has no trypanocidal activity (31). Although the growth of T. brucei is prevented when the
organism is cocultured with activated macrophages or chemical donors of NO, trypanosomes in vivo are protected from any toxic effects as a
result of their bloodstream habitat, in which hemoglobin acts as a sink
for NO production (12). Inhibition of NO synthase (NOS)
activity in the host with chemical inhibitors leads to reduced peak
parasitemia levels (23). In T. brucei infections,
the obverse of the general paradigm of NO as an antimicrobial effector
is therefore observed.
Thus, there is clear evidence linking production of NO by activated
macrophages to depression of cellular responses. There is also evidence
linking NO production to changes in parasitemia levels without a direct
action of NO on the parasites themselves. The question as to whether
the depression of cellular responses causes increases in parasitemia
therefore arises. Manipulation of inducible NO synthase (iNOS) activity
in trypanosome-infected mice should enable this question to be
addressed. Previous attempts to test the effects of NO on
parasitemia and the induction of anemia used inhibitors of NOS) that
suffered from a lack of specificity, as all isoforms were inhibited and
administration was tolerated by mice for only limited periods (11,
23). In the present study we sought direct evidence for the role
of iNOS in immunodepression and levels of T. brucei
parasitemia using iNOS-deficient mice.
Mice.
iNOS-deficient mice were generated as described
previously (32). Disruption of the murine iNOS gene was
achieved by homologous recombination in 129sv embryonic stem cells. The
recombinant allele was passed through the germ line following the
mating of the embryonic stem cell chimeras with MF-1 mice (Harlan Ltd.,
Oxon, United Kingdom). The homozygous and heterozygous mice thus
generated were backcrossed with MF-1 mice for three generations. All
the mice used were from the matings of littermates and should therefore
have had a similar genetic background. Peritoneal cells from mutant
mice did not produce iNOS protein following activation by IFN- Trypanosomes.
To initiate experimental infections, groups of
five adult female mice were inoculated with 104
trypanosomes/mouse via an intraperitoneal route with the cloned pleomorphic trypanosome line GUTat (Glasgow University
Trypanozoon antigen type) 7.2. This line produces resolving
infections in BALB/c mice in which more than 95% of the population
expresses the same variable antigen type (VAT), GUTat 7.2, during the
first wave of parasitemia (15). Two other VATs used in this
study, ILTat (ILRAD Trypanozoon antigen type) 1.3 and 1.61, are not expressed during the first 15 days of infection of the GUTat
7.2 line. In rabbits (which are less susceptible to infection than
mice) these two VATs are detected at approximately days 20 through 30 of infection (15, 27a). The parasitemia of each mouse was
monitored daily by removing 2 µl of blood and diluting it in 0.85%
NH4Cl in phosphate-buffered saline (PBS), and parasites
were counted by using an Improved Neubauer hemocytometer.
Isolation of mononuclear splenocytes.
Spleens were removed
from individual mice, and mononuclear splenocytes were isolated.
Briefly, spleens were disrupted through sterile tea strainers into RPMI
1640 medium and passed through 100-µm-pore-size monofilament nylon
filters to obtain single cell suspensions. Cymelarsan (Rhone-Merieux,
Lyon, France) was added to each suspension (including controls) at 50 µg/ml to kill contaminating trypanosomes, and suspensions from
infected mice were monitored by microscopy until lysis of trypanosomes
was observed (usually 10 to 30 min). The splenocytes were centrifuged,
and loose pellets were resuspended, layered onto cushions of Nycoprep
(Nycomed Ltd.), and centrifuged for 15 min at 700 × g.
The mononuclear interface layer was removed and centrifuged, and the
pellet was resuspended in 2 ml of medium. The cells were counted, their
viability was checked by trypan blue exclusion, and the cells were
resuspended at the required density. The centrifugation steps after
Cymelarsan treatment removed dead parasites from these preparations, as
judged by phase-contrast microscopy.
Flow cytometry analyses.
From each spleen, aliquots of
106 mononuclear splenocytes were made, resuspended in PBS
with 5% fetal calf serum and 0.05% azide in 50-µl volumes, and
double-labelled with phycoerythrin (PE)-conjugated anti-CD4 plus
fluorescein isothiocyanate (FITC)-conjugated anti-CD8, PE-conjugated
anti-CD4 plus FITC-conjugated anti-CD25 Proliferation assays.
The isolated mononuclear splenocytes
were plated out at 2 × 106 cells/well in 200-µl
aliquots in flat-bottomed 96-well microtiter plates with either medium
alone, concanavalin A (ConA) (8 µg/well; Sigma), or
paraformaldehyde-fixed trypanosomes (2 × 106/ml)
expressing GUTat 7.2, ILTat 1.3, or ILTat 1.61. The cells were
incubated at 37°C in 5% CO2 for 48 h and
radiolabelled with 1 µCi of [3H]thymidine per well for
the last 16 h before being harvested; results were read on a
Betaplate counter. The proliferative responses were determined by
[3H]thymidine incorporation, and results are expressed as
the mean counts per minute (± 2 standard errors [SE]) of four wells.
Cytokine assays.
The cells were dispensed into 24-well
plates at 4 × 106 cells/well in 1.25-ml volumes and
incubated with either medium alone, ConA (8 µg/well), or
paraformaldehyde-fixed trypanosomes (2 × 106/ml)
expressing GUTat 7.2, ILTat 1.3, or ILTat 1.61. The cells were
incubated at 37°C in 5% CO2, supernatants were harvested at 72 h and microcentrifuged for 30 s to remove cells, and
the cell-free supernatants were stored at Plasma nitrate levels.
The levels of nitrite and nitrate
present in the plasma from individual mice were measured by the
reduction of nitrate to nitrite and by the Griess reaction as
previously described (7, 12).
Statistical analyses.
Parasitemia data were analyzed by
repeated measures analysis of variance with log-transformed data, and
levels of IFN- Each experiment was conducted at least twice and produced the same
pattern of data on each occasion.
Comparison of parasitemia levels in iNOS-deficient and control
mice.
Levels of GUTat 7.2 parasitemia in iNOS-deficient and
control mice increased exponentially at similar rates and reached
similar densities at the peak of parasitemia on the same day
postinfection (Fig. 1). Parasitemic
decline after the parasitemic peak was different between the two groups
(F1, 6 = 43.0, P < 0.001), however,
with parasitemias in the iNOS-deficient mice decreasing more rapidly. From days 8 to 11 of infection there was an approximately
1-order-of-magnitude difference in levels of parasitemia between
iNOS-deficient and control mice. These levels of parasitemia in the
heterozygous MF-1 mice were higher than those previously described for
BALB/c mice (30); therefore, these experiments were
terminated on day 11 of infection, and several components of the immune
system were assayed.
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
T-Cell Responses during Trypanosoma
brucei Infections in Mice Deficient in Inducible Nitric
Oxide Synthase

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
) dependent (6). High levels of plasma
IFN-
occur early in infection (4), and one mechanism by which suppressor macrophages modulate lymphocyte function is via the
activation products nitric oxide (NO) and prostaglandins (13, 18,
20, 24). In murine trypanosomiasis, therefore, NO causes damage
to the lymphocyte function of the host. Recent studies on human and
nonhuman primate infections with T. brucei suggest that NO
production is elevated to levels similar to those found in the mouse
infection model (26), although the functional significance
in terms of immunodepression has yet to be determined.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
and
lipopolysaccharide in vitro as judged by Western blotting. They also
did not produce detectable amounts of NO after being cultured for
48 h with IFN-
and lipopolysaccharide. By 72 h, however, a
low level of nitrite was detectable in the culture supernatant of cells
from the iNOS-deficient mice. This may reflect either the accumulation
of nitrite produced by constitutive NOS (14) or the
induction of constitutive NOS (1, 17). iNOS-Deficient mice
remained competent for other aspects of macrophage function
(14). Female mutant mice and their heterozygous littermates
were used when 8 to 10 weeks old. Because only mice with an outbred
background were available, all assays were conducted on individual mice
to take into account the potential genetic variability.
chain, or PE-conjugated
anti-CD8 plus FITC-conjugated anti-CD25
chain (Pharmingen) at the
manufacturer's recommended concentrations for 1 h on ice. The
cells were washed twice in PBS-fetal calf serum and resuspended in 0.1 M Tris-0.9% NH4Cl for 10 min to lyse any contaminating
erythrocytes. The cells were pelleted by brief centrifugation,
resuspended in PBS (pH 7.0), and analyzed with a FACScan flow cytometer
(Becton Dickinson).
20°C until analysis by enzyme-linked immunosorbent assay for IFN-
, IL-2, and IL-5 with commercial capture and detection antibodies (Pharmingen).
and plasma nitrate were analyzed by Mann-Whitney U tests.
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

View larger version (17K):
[in a new window]
FIG. 1.
Time course of T. brucei parasitemia in
iNOS-deficient (
) and heterozygous control (
) mice inoculated
with 104 GUTat 7.2 parasites. Results are expressed as
geometric means ±2 SE for groups of five mice.
Cytometric analyses of mononuclear splenocytes. Expressing cytometric data in percentage terms fails to take into account the gross splenomegaly caused by trypanosomiasis; for this reason, our data are expressed as cell numbers per spleen. As a result of infection, CD4+-cell numbers increased in iNOS-deficient mice, and CD8+-cell numbers decreased slightly in both groups (Fig. 2). These changes caused the ratios of CD4+ cells to CD8+ cells to change from 2:1 to 8:1 in iNOS-deficient mice and from 3.8:1 to 7.3:1 in control mice. Figure 2 also shows that there were approximately fourfold more activated CD4+ cells (expressing CD25) present in the spleens from iNOS-deficient infected mice than in spleens from infected control or uninfected mice. Activated CD8+ cells were detected only in mononuclear splenocyte populations (in low numbers, 2 × 104/spleen) from infected iNOS-deficient mice.
|
Proliferative responses. The ability of the T cells to proliferate in response to ConA was examined (Fig. 3). High levels of proliferation were observed in splenocytes from infected mice in the absence of any stimulant, which is in accord with our previous observations, and we attribute these responses to increased numbers of activated cells in infected mice (5). Nevertheless, enhanced proliferation in response to ConA was seen in control mice (2.9-fold higher) and, most notably, in the iNOS-deficient mice (4.5-fold higher) (Fig. 3). Trypanosome-specific proliferation in response to paraformaldehyde-fixed parasites expressing one of the three VATs was not observed (data not shown). We attribute the difference in ConA-induced proliferative responses between iNOS-deficient and control mice to the way in which they respond to infection rather than to any intrinsic difference between the mice. No such differences were found between uninfected iNOS-deficient and control mice with an MF-1 genetic background in a previous study (14). Also, negligible differences were found in a study of iNOS-knockout mice with a C57BL/6 genetic background (10).
|
Cytokine production.
Mononuclear splenocytes from chronically
infected control and iNOS-deficient mice differed in the capacity to
produce IFN-
(Fig. 4). The control
mice produced very little IFN-
when stimulated with ConA or with any
of the three paraformaldehyde-fixed VATs. However, IFN-
production
by mononuclear splenocytes from the iNOS-deficient mice was very
different, with high levels produced in response to ConA (W = 15, P < 0.05) and trypanosomes expressing the homologous,
but not heterologous, VAT (W = 15, P < 0.05). The
heterologous VATs, ILTat 1.3 and 1.61, were both undetectable by
immunofluorescence analysis on days 7 and 11 of infection (data not
shown), indicating that splenocytes had no detectable exposure to these
VATs in vivo. The three trypanosome lines used to stimulate the
mononuclear cells are of the same genetic origin and thus differ
antigenically only in their VAT expression. All antigens except the
variant surface glycoproteins (VSGs) (the invariant antigens) were thus
the same in all three paraformaldehyde-fixed preparations. If invariant
antigens were strongly immunogenic in this assay, then equivalent
levels of IFN-
production would be expected, irrespective of which
antigen preparation was used as a stimulant. A similar result would
also be expected if the three VSGs shared epitopes. The data shown
in Fig. 4 thus confirm that VSG is the main immunogen of T. brucei and indicate VAT-specific stimulation of IFN-
production.
|
Plasma nitrite and nitrate. In control and iNOS-deficient uninfected mice, the mean concentrations of nitrate (±2 SE) were 24.7 ± 4.1 and 18.8 ± 2.9 µM, respectively. In the infected control mice there was a 6.7-fold increase in plasma nitrate levels, to 165.0 ± 45.3 µM (W = 49, P = 0.023), and a 3.8-fold increase in the iNOS-deficient infected mice, to 70.8 ± 7.9 µM (W = 56, P = 0.011).
| |
DISCUSSION |
|---|
|
|
|---|
Abrogation of iNOS activity had a marked affect on all indices of
T-cell competence. Numbers of splenic CD4+ cells and
activated CD4+ cells expressing the IL-2 receptor increased
as a result of infection in the iNOS-deficient mice, whereas
CD8+ cell numbers decreased and CD25 CD8 double-positive
cells occurred only rarely. These data are consistent with previous
observations that the T-cell response in T. brucei infection
is mainly CD4 mediated (19) rather than CD8 mediated
(3, 16). These data are also in agreement with the
observation of a proliferative response to ConA and of the ability to
generate IFN-
, but not IL-5, in response to both ConA and specific
antigen, indicating that there is a depression of T-cell responses
(2, 5, 6, 8, 13, 18, 20, 22, 25) caused by NO and that
responsiveness is restored on removal of NO (13, 18, 23,
24). The extent of the recovery of T-cell competence in the
iNOS-deficient mice was sufficient to cause a change in parasitemia but
has not been determined directly. A prediction would be that the
recovery was incomplete, given that we observed raised levels of plasma
nitrate in the iNOS-deficient mice and as a result of continued
immunodepressive prostaglandin synthesis (18, 21). This
prediction is consistent with our observation of trypanosome
VAT-specific responsiveness detected by the IFN-
assay but
proliferative responsiveness detected only with mitogen. IFN-
production in the absence of a proliferative response has been
previously observed in peritoneal T cells from T. brucei-infected mice (19). Our results suggest that on
day 11 of infection in this mouse model there was a generalized
depression of T-cell responses, but a deficiency in NO production
restored some cellular competence. The observation that the numbers of splenic CD4+ cells and activated CD4+ cells
increased in iNOS-deficient mice, together with the detection of
IFN-
, but not IL-5, production from splenocytes, suggests that the
cellular response is T-helper 1-like.
Our parasitology data contrast with the results from studies using NOS inhibitors, which showed a reduction in peak levels of parasitemia but no difference in rates of parasite clearance (23). This discrepancy may be due to the use of different mouse and parasite strains but also may reflect levels and sources of NO. NG-nitro-L-arginine methyl ester (L-NAME) causes a quantitative reduction in NO production by all isoforms of NOS, whereas in the present study iNOS activity was abrogated but other isoforms were unaffected. We have some evidence for compensatory production of NO from a source other than iNOS in the elevated levels of plasma nitrate in the infected iNOS-deficient mice. A low level of production of NO has been observed previously in culture supernatants of peritoneal cells from these iNOS-deficient mice (14). These elevated levels of nitrate may reflect the induction of constitutive isoforms of NOS, as has been demonstrated under other circumstances (1, 17).
It has been suggested that while NO is a mediator of immunodepression in mice, it is not so in cattle (27). However, most of the murine studies have been conducted with T. brucei, whereas the cattle study was based on Trypanosoma congolense, and these two species differ in an important aspect of their biology. T. congolense parasites adhere to the vascular endothelium whereas T. brucei does not. Macrophage activation happens mainly in the spleen and liver, but the rate of movement of trypanosomes through these organs is expected to be considerably lower for T. congolense. Thus, the quantitative extent, and perhaps qualitative nature, of macrophage activation would be expected to be very different for the two species. Studies on T. congolense-infected iNOS-deficient mice are clearly warranted.
Our results suggest that as a result of NO production, parasitemia levels declined more slowly after the first peak and indices of cellular responsiveness were lower. Establishing this link between depression and a higher level of parasitemia after the first peak is important because it has been postulated that the generation of immunodepression is an immune evasion strategy (2). This postulate can only be true, however, if depression is of selective advantage to the parasite (in evolutionary terms) rather than merely disadvantageous to the host (28). It is only by increasing the level of parasitemia, and thus promoting transmission of parasites from mammals to the tsetse fly, that a selective advantage can be obtained. The implication from our data is that trypanosomes contain genetically determined mechanisms for causing immunodepression.
| |
ACKNOWLEDGMENTS |
|---|
We thank the UK Medical Research Council and The Wellcome Trust for financial support.
We thank John Mansfield for sharing unpublished data. Cymelarsan was a kind gift from Rhone-Merieux.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Division of Infection & Immunity, I.B.L.S., Joseph Black Building, University of Glasgow, Glasgow G12 8QQ, United Kingdom. Phone: (44) 141-330-6629. Fax: (44) 141-330-3516. E-mail: m.turner{at}bio.gla.ac.uk.
Present address: Department of Pediatrics, University of
Washington, Seattle, WA 98195.
Editor: J. M. Mansfield
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Amin, A. R.,
P. E. Di Cesare,
P. Vyas,
M. Attur,
E. Tzeng,
T. R. Billiar,
S. A. Stuchin, and S. B. Abramson.
1995.
The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase.
J. Exp. Med.
182:2097-2102 |
| 2. | Askonas, B. A. 1985. Macrophages as mediators of immunosuppression in murine African trypanosomiasis. Curr. Top. Microbiol. Immunol. 117:119-127[Medline]. |
| 3. | Bakhiet, M., T. Olsson, P. van der Meide, and K. Kristensson. 1990. Depletion of CD8+ T cells suppresses growth of Trypanosoma brucei brucei and interferon-gamma production in infected rats. Clin. Exp. Immunol. 81:195-199[Medline]. |
| 4. | Bancroft, G. J., A. G. Sutton, A. J. Morris, and B. A. Askonas. 1983. Production of interferons during experimental African trypanosomiasis. Clin. Exp. Immunol. 52:135-143[Medline]. |
| 5. | Borowy, N. K., J. M. Sternberg, D. Schreiber, C. Nonnengasser, and P. Overath. 1990. Suppressive macrophages occurring in murine Trypanosoma brucei infection inhibit T-cell responses in vivo and in vitro. Parasite Immunol. 12:233-246[Medline]. |
| 6. |
Darji, A.,
M. Sileghem,
H. Heremans,
L. Brys, and P. De Baetselier.
1993.
Inhibition of T-cell responsiveness during experimental infections with Trypanosoma brucei: active involvement of endogenous gamma interferon.
Infect. Immun.
61:3098-3102 |
| 7. | Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2412[Abstract]. |
| 8. | Flynn, J. N., and M. Sileghem. 1991. The role of the macrophage in induction of immunosuppression in Trypanosoma congelense infected cattle. Immunology 74:310-316[Medline]. |
| 9. | Ghiotto, V., R. Brun, L. Jenni, and H. Hecker. 1979. Trypanosoma brucei: morphometric changes and loss of infectivity during transformation of bloodstream forms to procyclic culture forms in vitro. Exp. Parasitol. 48:447-456[Medline]. |
| 10. |
Hertz, C. J., and J. M. Mansfield.
1999.
IFN- -dependent nitric oxide production is not linked to resistance in experimental African trypanosomiasis.
Cell. Immunol.
192:24-32[Medline].
|
| 11. | Mabbott, N., and J. Sternberg. 1995. Bone marrow nitric oxide production and development of anemia in Trypanosoma brucei-infected mice. Infect. Immun. 63:1563-1566[Abstract]. |
| 12. | Mabbott, N. A., I. A. Sutherland, and J. M. Sternberg. 1994. Trypanosoma brucei is protected from the cytostatic effects of nitric oxide under in vivo conditions. Parasitol. Res. 80:687-690[Medline]. |
| 13. | Mabbott, N. A., I. A. Sutherland, and J. M. Sternberg. 1995. Suppressor macrophages in Trypanosoma brucei infection: nitric oxide is related to both suppressive activity and lifespan in vivo. Parasite Immunol. 17:143-150[Medline]. |
| 14. |
McInnes, I. B.,
B. Leung,
X.-Q. Wei,
C. G. Gemmell, and F. Y. Liew.
1998.
Septic arthritis following Staphylococcus aureus infection in mice lacking inducible nitric oxide synthase.
J. Immunol.
160:308-315 |
| 15. | McLintock, L. M. L., C. M. R. Turner, and K. Vickerman. 1990. A comparison of multiplication rates in primary and challenge infections of Trypanosoma brucei bloodstream forms. Parasitology 101:49-55. |
| 16. | Olsson, T., M. Bakhiet, B. Hojeberg, A. Ljungdahl, C. Edlund, G. Andersson, H. P. Ekre, W. P. Fung-Leung, T. Mak, H. Wigzell, U. Fiszer, and K. Kristensson. 1993. CD8 is critically involved in lymphocyte activation by a T. brucei-released molecule. Cell 72:715-727[Medline]. |
| 17. |
Samdani, A. F.,
C. Newcamp,
A. Resink,
F. Facchinetti,
B. E. Hoffman,
V. L. Dawson, and T. M. Dawson.
1997.
Differential susceptibility to neurotoxicity mediated by neurotrophins and neural nitric oxide synthase.
J. Neurosci.
17:4633-4641 |
| 18. | Schleifer, K. W., and J. M. Mansfield. 1993. Suppressor macrophages in African trypanosomiasis inhibit T-cell proliferative responses by nitric oxide and prostaglandins. J. Immunol. 151:5492-5503[Abstract]. |
| 19. | Schleifer, K. W., H. Filutowicz, L. R. Schopf, and J. M. Mansfield. 1993. Characterisation of T helper cell responses to the trypanosome variant surface glycoprotein. J. Immunol. 150:2910-2919[Abstract]. |
| 20. | Sileghem, M., A. Darji, R. Hamers, M. Van de Winkel, and P. De Baetselier. 1989. Dual role of macrophages in the suppression of interleukin 2 production and interleukin 2 receptor expression in trypanosome-infected mice. Eur. J. Immunol. 19:829-835[Medline]. |
| 21. | Sileghem, M., A. Darji, and P. De Baetselier. 1991. In vitro stimulation of immunosuppression caused by Trypanosoma brucei. Immunology 73:246-248[Medline]. |
| 22. | Sileghem, M., and J. N. Flynn. 1992. Suppression of interleukin 2 secretion and interleukin 2 receptor expression during tsetse-transmitted trypanosomiasis in cattle. Eur. J. Immunol. 22:767-773[Medline]. |
| 23. |
Sternberg, J.,
N. Mabbott,
I. Sutherland, and F. Y. Liew.
1994.
Inhibition of nitric oxide synthesis leads to reduced parasitemia in murine Trypanosoma brucei infection.
Infect. Immun.
62:2135-2137 |
| 24. | Sternberg, J. M., and F. McGuigan. 1992. Nitric oxide mediates suppression of T-cell responses in murine Trypanosoma brucei infection. Eur. J. Immunol. 22:2741-2744[Medline]. |
| 25. | Sternberg, J. M. 1998. Immunobiology of African trypanosomiasis. Chem. Immunol. 70:186-199[Medline]. |
| 26. | Sternberg, J. M., N. Njogu-Maina, C. Gichuki, and J. M. Ndung'u. 1998. Nitric oxide production in vervet monkeys (Cercopithecus aethiops) infected with Trypanosoma brucei. Parasite Immunol. 20:395-397[Medline]. |
| 27. | Taylor, K., V. Lutje, and B. Mertens. 1996. Nitric oxide synthesis is depressed in Bos indicus cattle infected with Trypanosoma congolense and Trypanosoma vivax and does not mediate T-cell suppression. Infect. Immun. 64:4115-4122[Abstract]. |
| 27a. | Turner, C. M. R. Unpublished results. |
| 28. | Turner, C. M. R. Antigenic variation in Trypanosoma brucei: a holistic view. J. Cell Sci., in press. |
| 29. | Turner, C. M. R., and J. D. Barry. 1989. High frequency of antigenic variation in Trypanosoma brucei rhodesiense infections. Parasitology 99:67-75. |
| 30. | Turner, C. M. R., N. Aslam, and S. D. Angus. 1996. Inhibition of growth of Trypanosoma brucei parasites in chronic infections. Parasitol. Res. 82:61-66[Medline]. |
| 31. | Vincendeau, P., S. Daulouède, B. Veyret, M. L. Darde, B. Bouteille, and J. P. Lemesre. 1992. Nitric oxide-mediated cytostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei brucei. Exp. Parasitol. 75:353-360[Medline]. |
| 32. | Wei, X.-Q., I. G. Charles, A. Smith, J. Ure, G.-J. Feng, F.-P. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408-411[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»